Earnings call transcript: Covista Q3 2026 sees strong revenue growth

Covista delivered a strong Q3, with revenue up 4.5% year over year to $487 million and adjusted EBITDA of $127.9 million, or $145.9 million excluding timing impacts, with margin up 150 bps. The company raised full-year revenue guidance to $1.93 billion-$1.945 billion and EPS guidance to $7.95-$8.15, while total enrollment surpassed 100,000 students for the 11th straight quarter of growth. Free cash flow rose 17% to $336 million, supporting $66 million of buybacks and continued campus/AI investment.

Analysis

The key second-order read-through is that ATGE is transitioning from a “recovery story” to a self-funding compounder. The combination of stronger enrollment, margin expansion, and lower leverage means incremental growth now drops disproportionately to equity value, especially if management sustains buybacks while still funding campus expansion and AI initiatives. That mix usually re-rates a name more on capital efficiency than on headline revenue growth.

The most important operational signal is not the beat itself but the improved conversion quality underneath it. When funnel conversion normalizes after a marketing misstep, the market often underestimates how quickly earnings power snaps back because the earlier weakness depresses comparison points for several quarters. That creates a setup where Q4 and early FY27 could show cleaner upside than this quarter if enrollment strength persists into the fall cycle.

The contrarian issue is that consensus may still be modeling ATGE like a cyclical education operator, when the balance-sheet and cash-flow profile increasingly resembles a cash-return platform with embedded growth optionality. That said, the biggest near-term risk is self-inflicted: if campus buildout and strategic investments ramp faster than enrollment capacity can absorb them, margins could plateau even while revenue holds up. Longer-dated risk is policy/regulatory pressure around healthcare education economics, but that is a months-to-years issue, not a near-term earnings problem.

SSM is the cleaner thematic beneficiary on the employer-partnership angle, but the market is likely underpricing the broader ecosystem effect: if employer-funded education becomes repeatable, ATGE could reduce student-acquisition costs and improve placement outcomes simultaneously. That would strengthen moat, compress payback periods on growth spend, and make future guidance less dependent on pure marketing efficiency. The AI curriculum angle is also more valuable as a distribution lever than a headline tech story, because it can deepen enterprise relationships and improve student persistence rather than simply add a new product line.

Key Decisions for Investors

• Long ATGE on a 3-6 month horizon; add on any post-earnings consolidation. Risk/reward favors a re-rate if FY27 expectations begin to incorporate cleaner enrollment growth and buyback support, with downside limited by cash flow and low leverage.
• Buy ATGE Jan-2027 call spreads to express upside from continued margin expansion and Q4/FY27 guidance lift. Prefer spreads over outright calls to reduce premium burn if the stock stays rangebound while campus investment ramps.
• Pair trade: long ATGE / short a slower-growth education peer with higher leverage and weaker cash conversion over the next 1-2 quarters. The thesis is that ATGE’s balance sheet and capital-return capacity should outperform on any sector rotation into quality.
• For event-driven accounts, use dips after guidance-driven mean reversion to build longs rather than chasing strength intraday. The next catalyst window is the fall enrollment cycle, where confirmation of Chamberlain normalization could reset estimates again.
• Monitor SSM as a secondary beneficiary; any additional employer-partnership announcements could be a catalyst for a sympathy move, but the cleaner trade remains ATGE because it monetizes the partnership narrative through scale and capital returns.